Ushbu preparat yaxshi tolerantlikka ega, engil va o'rtacha darajadagi salbiy reaktsiyalar, ko'pincha vaqtinchalik, quyidagicha:
1. Bosh og'rig'i (10,5 foiz), bosh aylanishi (1,8 foiz), yuzning qizarishi (11,6 foiz), ovqat hazm qilish buzilishi (2,7 foiz), ko'ngil aynishi (1,2 foiz) va rinit (4,4 foiz) 1 foizdan ortiq kasallanish darajasi aniqlangan. nazorat qilinadigan klinik sinovlarda.
2. Global klinik sinovlar (1) juda tez-tez uchraydi (10 foizdan ortiq yoki unga teng bo'lgan holatlar): bosh og'rig'i va yuzning qizarishi. (2) Umumiy (1 foiz kasallanishdan kamroq yoki teng<10%): indigestion, nausea, dizziness, rhinitis. (3) Rare (0.1% ≤ incidence<1%): facial edema, photosensitive reaction, backache, hypertension, lethargy, dyspnea, visual abnormalities, lacrimation, Priapism (including erection elongation or pain), abnormal liver function, myalgia, and elevated Creatine kinase. (4) Rare (0.01% ≤ incidence<0.1%): allergic reaction (including laryngeal edema), Hypotension, angina pectoris, myocardial ischemia, orthostatic Hypotension, syncope, nervous tension, glaucoma, epistaxis.
3. Miokard infarkti haqida xabarlar mavjud.
